Close
  Indian J Med Microbiol
 

Figure 1: Effect of arbutin on the nasal symptoms of OVA-provoked AR in mice. The arbutin (25 and 50 mg/kg) supplementation to the OVA-challenged AR mice demonstrated the decreased numbers of sneezing and nasal rubbing. Results were displayed as mean ± SD of triplicates. The one-way ANOVA afterward DMRT study was executed to determine the significance level; *P < 0.05 when related with control and #P < 0.05 when related with OVA-group. Group I: control; Group II: OVA-provoked AR animals; Groups III and IV: AR with 25 and 50 mg/kg of arbutin treatment, respectively; and Group V: 2.5 mg of standard drug dexamethasone-treated AR animals. AR: Allergic rhinitis; OVA: Ovalbumin; SD: Standard deviation

Figure 1: Effect of arbutin on the nasal symptoms of OVA-provoked AR in mice. The arbutin (25 and 50 mg/kg) supplementation to the OVA-challenged AR mice demonstrated the decreased numbers of sneezing and nasal rubbing. Results were displayed as mean ± SD of triplicates. The one-way ANOVA afterward DMRT study was executed to determine the significance level; *<i>P</i> < 0.05 when related with control and <sup>#</sup><i>P</i> < 0.05 when related with OVA-group. Group I: control; Group II: OVA-provoked AR animals; Groups III and IV: AR with 25 and 50 mg/kg of arbutin treatment, respectively; and Group V: 2.5 mg of standard drug dexamethasone-treated AR animals. AR: Allergic rhinitis; OVA: Ovalbumin; SD: Standard deviation